OP14 Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE studyWilliam J. Sandborn, Edward V. Loftus, Fabio Cataldi et al.|Journal of Crohn s and Colitis|2019Cited by 9
P601 Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn’s disease: Data from the CELEST studyRemo Panaccione, Aileen L. Pangan, Raja Atreya et al.|Journal of Crohn s and Colitis|2018Cited by 7
P435 Rapidity of symptomatic and inflammatory biomarker improvements following upadacitinib induction treatment: data from the U-ACHIEVE studyGeert D’Haens, Séverine Vermeire, Wenhui Xie et al.|Journal of Crohn s and Colitis|2019Cited by 1